Company: VRCA
Filing Date: 2025-04-11
Form Type: PRE 14A
Source: 0001193125-25-079118
Chunk: 48

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-11
Form: PRE 14A
Chunk 48
---
 15, 2026, March 15, 2027 and March 15, 2028, subject to the holders’ continuous service through each applicable date. |

Narrative to Summary Compensation Table We review compensation annually for all employees, including our executives. In setting executive base salaries and bonuses and granting equity incentive awards, we consider compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders, and a long-term commitment to our company. We do not target a specific competitive position or a specific mix of compensation among base salary, bonus or long-term incentives. The Compensation Committee of our Board of Directors has historically determined our executives’ compensation. Our Compensation Committee typically reviews and discusses management’s proposed compensation with the Chief Executive Officer for all executives other than the Chief Executive Officer. Based on those discussions and its discretion, the Compensation Committee then recommends the compensation for each executive officer. Our Compensation Committee, without members of management present, discusses and ultimately approves the compensation of our executive officers. 37

Annual Base Salary We have entered into employment agreements with each of our named executive officers that establish annual base salaries, which are generally determined, approved and reviewed periodically by our Compensation Committee in order to compensate our named executive officers for the satisfactory performance of duties to us. The following table presents the annual base salaries for each of our named executive officers for the years indicated.

| Name                 |     | 2025 Base 
 Salary    
 ($)       |         |     | 2024 Base 
 Salary    
 ($)       |         |
| Jayson Rieger(1)     |     |           | 300,000 |     |           | 300,000 |
| Christopher G. Hayes |     |           | 466,000 |     |           | 466,000 |
| Gary Goldenberg(2)   |     |           |       — |     |           | 462,800 |
| Ted White(3)         |     |           |       — |     |           | 624,624 |
| Joe Bonaccorso(4)    |     |           |       — |     |           | 461,760 |

| (1) | Dr. Rieger’s employment as our President and Chief Executive Officer began on November 6, 2024, and the salary amount reported in the Summary Compensation Table above